Bone Biologics Corporation

NasdaqCM:BBLG Stock Report

Market Cap: US$2.4m

Bone Biologics Future Growth

Future criteria checks 0/6

Bone Biologics is forecast to grow earnings at 34.6% per annum. EPS is expected to grow by 39.6% per annum.

Key information

34.6%

Earnings growth rate

39.6%

EPS growth rate

Biotechs earnings growth23.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

Low

Last updated27 Feb 2025

Recent future growth updates

Recent updates

Companies Like Bone Biologics (NASDAQ:BBLG) Are In A Position To Invest In Growth

Jun 07
Companies Like Bone Biologics (NASDAQ:BBLG) Are In A Position To Invest In Growth

Bone Biologics prices $5.1M underwritten public offering

Oct 07

We're Not Very Worried About Bone Biologics' (NASDAQ:BBLG) Cash Burn Rate

Mar 18
We're Not Very Worried About Bone Biologics' (NASDAQ:BBLG) Cash Burn Rate

Earnings and Revenue Growth Forecasts

NasdaqCM:BBLG - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026N/A-4N/AN/A1
12/31/2025N/A-4N/AN/A1
12/31/2024N/A-7-4-4N/A
9/30/2024N/A-7-5-5N/A
6/30/2024N/A-5-7-7N/A
3/31/2024N/A-6-10-10N/A
12/31/2023N/A-9-10-10N/A
9/30/2023N/A-7-9-9N/A
6/30/2023N/A-6-7-7N/A
3/31/2023N/A-5-4-4N/A
12/31/2022N/A-1-4-4N/A
9/30/2022N/A-3-2-2N/A
6/30/2022N/A-2-2-2N/A
3/31/2022N/A-2-2-2N/A
12/31/2021N/A-2-1-1N/A
9/30/2021N/A-2-1-1N/A
6/30/2021N/A-2-1-1N/A
3/31/2021N/A-200N/A
12/31/2020N/A-200N/A
9/30/2020N/A-2-1-1N/A
6/30/2020N/A-2-1-1N/A
3/31/2020N/A-3-2-2N/A
12/31/2019N/A-3-3-3N/A
9/30/2019N/A-4-4-4N/A
6/30/2019N/A-4-5-5N/A
3/31/2019N/A-4-4-4N/A
12/31/2018N/A-4-4-4N/A
9/30/2018N/A-6N/A-4N/A
6/30/2018N/A-8N/A-3N/A
3/31/2018N/A-6N/A-3N/A
12/31/2017N/A-7N/A-3N/A
9/30/2017N/A-14N/A-4N/A
6/30/2017N/A-16N/A-5N/A
3/31/2017N/A-22N/A-6N/A
12/31/2016N/A-26N/A-7N/A
9/30/2016N/A-24N/A-7N/A
6/30/2016N/A-23N/A-7N/A
3/31/2016N/A-19N/A-6N/A
12/31/2015N/A-14N/A-4N/A
9/30/2015N/A-7N/A-4N/A
6/30/2015N/A-6N/A-4N/A
3/31/2015N/A-6N/A-3N/A
12/31/2014N/A-4N/A-3N/A
9/30/2014N/A-4N/A-1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BBLG is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: BBLG is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: BBLG is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: Insufficient data to determine if BBLG's revenue is forecast to grow faster than the US market.

High Growth Revenue: BBLG is forecast to have no revenue next year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if BBLG's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/05 21:27
End of Day Share Price 2025/05/05 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bone Biologics Corporation is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bradley SorensenZacks Small-Cap Research